166 related articles for article (PubMed ID: 8396203)
1. Oral itraconazole versus topical bifonazole treatment in experimental dermatophytosis.
Borgers M; Xhonneux B; Van Cutsem J
Mycoses; 1993; 36(3-4):105-15. PubMed ID: 8396203
[TBL] [Abstract][Full Text] [Related]
2. Dermatophytosis: the management of fungal infections.
Gupta AK; Ryder JE; Chow M; Cooper EA
Skinmed; 2005; 4(5):305-10. PubMed ID: 16282753
[TBL] [Abstract][Full Text] [Related]
3. Effects of butenafine hydrochloride, a new benzylamine derivative, on experimental dermatophytosis in guinea pigs.
Arika T; Yokoo M; Hase T; Maeda T; Amemiya K; Yamaguchi H
Antimicrob Agents Chemother; 1990 Nov; 34(11):2250-3. PubMed ID: 2073116
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of terbinafine compared to lanoconazole and luliconazole in the topical treatment of dermatophytosis in a guinea pig model.
Ghannoum MA; Long L; Kim HG; Cirino AJ; Miller AR; Mallefet P
Med Mycol; 2010 May; 48(3):491-7. PubMed ID: 20370362
[TBL] [Abstract][Full Text] [Related]
5. Antimycotic azoles. 7. Synthesis and antifungal properties of a series of novel triazol-3-ones.
Heeres J; Backx LJ; Van Cutsem J
J Med Chem; 1984 Jul; 27(7):894-900. PubMed ID: 6330360
[TBL] [Abstract][Full Text] [Related]
6. Pyrrolo[1,2-α][1,4]benzodiazepines show potent in vitro antifungal activity and significant in vivo efficacy in a Microsporum canis dermatitis model in guinea pigs.
Paulussen C; de Wit K; Boulet G; Cos P; Meerpoel L; Maes L
J Antimicrob Chemother; 2014 Jun; 69(6):1608-10. PubMed ID: 24535279
[TBL] [Abstract][Full Text] [Related]
7. Linalool modulates dermatophyte susceptibility to azole drugs.
Ponte HAS; Lima MIO; Lima EO; Pereira FO
Med Mycol; 2020 Feb; 58(2):272-274. PubMed ID: 31329906
[TBL] [Abstract][Full Text] [Related]
8. Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models.
Van Cutsem J; Van Gerven F; Janssen PA
Rev Infect Dis; 1987; 9 Suppl 1():S15-32. PubMed ID: 3027843
[TBL] [Abstract][Full Text] [Related]
9. Ketoconazole (R 41 400) in the treatment of dermatophyte infections: a clinical, mycological, and morphological study.
Degreef H; Van de Kerckhove M; Gevers D; Van Cutsem J; Van den Bossche H; Borgers M
Int J Dermatol; 1981 Dec; 20(10):662-9. PubMed ID: 6276309
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation the antimycotic activity of itraconazole in human stratum corneum with vitro fungi cultivation].
Xu W; Zhao JY; Wang L
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):530-3. PubMed ID: 15949332
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the growth in vitro of Trichophyton mentagrophytes, Trichophyton erinacei and Microsporum persicolor by miconazole and chlorhexidine.
Perrins N; Howell SA; Moore M; Bond R
Vet Dermatol; 2005 Oct; 16(5):330-3. PubMed ID: 16238813
[TBL] [Abstract][Full Text] [Related]
12. Ultrastructural changes on clinical isolates of Trichophyton rubrum, Trichophyton mentagrophytes, and Microsporum gypseum caused by Solanum chrysotrichum saponin SC-2.
López-Villegas EO; Herrera-Arellano A; de Los Angeles Martínez-Rivera M; Alvarez L; Cano-Nepauseno M; Marquina S; Rodríguez-Tovar AV; Tortoriello J
Planta Med; 2009 Nov; 75(14):1517-20. PubMed ID: 19551614
[TBL] [Abstract][Full Text] [Related]
13. The use of itraconazole to treat cutaneous fungal infections in children.
Gupta AK; Nolting S; de Prost Y; Delescluse J; Degreef H; Theissen U; Wallace R; Marynissen G; De Doncker P
Dermatology; 1999; 199(3):248-52. PubMed ID: 10592406
[TBL] [Abstract][Full Text] [Related]
14. Effect of Lamisil and azole antifungals in experimental nail infection.
Richardson MD
Dermatology; 1997; 194 Suppl 1():27-31. PubMed ID: 9154398
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo activities of the novel azole antifungal agent r126638.
Odds F; Ausma J; Van Gerven F; Woestenborghs F; Meerpoel L; Heeres J; Vanden Bossche H; Borgers M
Antimicrob Agents Chemother; 2004 Feb; 48(2):388-91. PubMed ID: 14742185
[TBL] [Abstract][Full Text] [Related]
16. Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens.
Cetinkaya Z; Kiraz N; Karaca S; Kulac M; Ciftci IH; Aktepe OC; Altindis M; Kiyildi N; Piyade M
Eur J Dermatol; 2005; 15(4):258-61. PubMed ID: 16048753
[TBL] [Abstract][Full Text] [Related]
17. Fungal infections of the skin: infection process and antimycotic therapy.
Borgers M; Degreef H; Cauwenbergh G
Curr Drug Targets; 2005 Dec; 6(8):849-62. PubMed ID: 16375669
[TBL] [Abstract][Full Text] [Related]
18. Experimental guinea pig model of dermatophytosis: a simple and useful tool for the evaluation of new diagnostics and antifungals.
Saunte DM; Hasselby JP; Brillowska-Dabrowska A; Frimodt-Møller N; Svejgaard EL; Linnemann D; Nielsen SS; Haedersdal M; Arendrup MC
Med Mycol; 2008 Jun; 46(4):303-13. PubMed ID: 18415837
[TBL] [Abstract][Full Text] [Related]
19. New and prospective developments in antifungal drugs.
Cauwenbergh G
Acta Derm Venereol Suppl (Stockh); 1986; 121():147-53. PubMed ID: 3012922
[TBL] [Abstract][Full Text] [Related]
20. The novel azole R126638 is a selective inhibitor of ergosterol synthesis in Candida albicans, Trichophyton spp., and Microsporum canis.
Vanden Bossche H; Ausma J; Bohets H; Vermuyten K; Willemsens G; Marichal P; Meerpoel L; Odds F; Borgers M
Antimicrob Agents Chemother; 2004 Sep; 48(9):3272-8. PubMed ID: 15328084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
